Advising customers on Omeprazole 20mg use
ADVISING CUSTOMERS ON OMEPRAZOLE 20mg USE
IMPORTANT It can take 2 to 3 days to achieve symptom improvement.
Customers can use antacids for their symptoms while waiting for the
product to have full effect.
Click the arrows next to the slider for potential interactions/cautions
and side effects
INTERACTIONS/CAUTIONS
Pyrocalm Control tablets (Omeprazole 20mg) shouldn't be taken by customers who are using other PPIs or H2-antagonists (e.g. ranitidine). It interacts with nelfinavir. Customers with any allergies to the ingredients or previous sensitivities to other PPIs shouldn't take Pyrocalm Control tablets (Omeprazole 20mg).
Remind customers to read the leaflet as there are other medicines that may interact; for example, omeprazole can decrease the absorption of ketoconazole so customers can be advised to take ketoconazole with an acidic drink.
Customers taking other medicines (including herbal/supplements) should discuss these with the pharmacist.
Pyrocalm Control tablets (Omeprazole 20mg) may be used by pregnant women, but customers may wish to consult their GP first.
SIDE EFFECTS
As with all medicines, there are potential side-effects. Common side-effects include headache, gastrointestinal effects and nausea. Rare, but serious signs to be aware of are: allergy, reddening of the skin and peeling (potentially Stevens-Johnson syndrome), yellowing skin/dark urine indicating liver problems, bruising/severely reduced general condition and fever (indicating changes in white blood cells).
Any new side-effects should be recorded using the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
INTERACTIONS/CAUTIONS
Pyrocalm Control tablets (Omeprazole 20mg) shouldn't be taken by customers who are using other PPIs or H2-antagonists (e.g. ranitidine). It interacts with nelfinavir. Customers with any allergies to the ingredients or previous sensitivities to other PPIs shouldn't take Pyrocalm Control tablets (Omeprazole 20mg).
Remind customers to read the leaflet as there are other medicines that may interact; for example, omeprazole can decrease the absorption of ketoconazole so customers can be advised to take ketoconazole with an acidic drink.
Customers taking other medicines (including herbal/supplements) should discuss these with the pharmacist.
Pyrocalm Control tablets (Omeprazole 20mg) may be used by pregnant women, but customers may wish to consult their GP first.
SIDE EFFECTS
As with all medicines, there are potential side-effects. Common side-effects include headache, gastrointestinal effects and nausea. Rare, but serious signs to be aware of are: allergy, reddening of the skin and peeling (potentially Stevens-Johnson syndrome), yellowing skin/dark urine indicating liver problems, bruising/severely reduced general condition and fever (indicating changes in white blood cells).
Any new side-effects should be recorded using the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
INTERACTIONS/CAUTIONS
Pyrocalm Control tablets (Omeprazole 20mg) shouldn't be taken by customers who are using other PPIs or H2-antagonists (e.g. ranitidine). It interacts with nelfinavir. Customers with any allergies to the ingredients or previous sensitivities to other PPIs shouldn't take Pyrocalm Control tablets (Omeprazole 20mg).
Remind customers to read the leaflet as there are other medicines that may interact; for example, omeprazole can decrease the absorption of ketoconazole so customers can be advised to take ketoconazole with an acidic drink.
Customers taking other medicines (including herbal/supplements) should discuss these with the pharmacist.
Pyrocalm Control tablets (Omeprazole 20mg) may be used by pregnant women, but customers may wish to consult their GP first.
SIDE EFFECTS
As with all medicines, there are potential side-effects. Common side-effects include headache, gastrointestinal effects and nausea. Rare, but serious signs to be aware of are: allergy, reddening of the skin and peeling (potentially Stevens-Johnson syndrome), yellowing skin/dark urine indicating liver problems, bruising/severely reduced general condition and fever (indicating changes in white blood cells).
Any new side-effects should be recorded using the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
